Voya Investment Management LLC Purchases 3,855 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Voya Investment Management LLC increased its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 1.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 224,559 shares of the company's stock after purchasing an additional 3,855 shares during the quarter. Voya Investment Management LLC owned 1.24% of Addus HomeCare worth $28,148,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Natixis grew its position in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the period. Smartleaf Asset Management LLC increased its position in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after buying an additional 214 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after buying an additional 148 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in Addus HomeCare in the 4th quarter worth approximately $86,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ADUS shares. Stephens reiterated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Macquarie reissued an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Oppenheimer boosted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Finally, JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. One analyst has rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Addus HomeCare currently has an average rating of "Buy" and an average target price of $139.00.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS traded up $1.15 during trading hours on Friday, hitting $105.07. 61,722 shares of the company's stock traded hands, compared to its average volume of 163,008. The business has a fifty day moving average price of $97.31 and a 200-day moving average price of $115.42. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72. The firm has a market capitalization of $1.91 billion, a P/E ratio of 24.00, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.